Skip to content

Clinical trials

Completed Phase 1/2 Central Nervous System Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Central Nervous System Diseases Phase: Phase 1/2 Status: Completed Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20091
20102
20112
20191
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center2
AC Immune SA1
BBB-Therapeutics B.V.1
Children's Hospital Medical Center, Cincinnati1
Eisai Inc.1
Southern Medical University, China1
TVAX Biomedical1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Central Nervous System Diseases8
Brain Diseases4
Brain Neoplasms4
Alzheimer Disease2
Central Nervous System Neoplasms2
Glioblastoma2
Glioma2
Neoplasms2
Nervous System Diseases2
Nervous System Neoplasms2

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.